Fungal cell wall: An underexploited target for antifungal therapies
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Cell wall architecture The cell wall of the major fungal pathogen Candida albicans consists of an outer layer that is made up of highly mannosylated proteins. The proteins are attached to the inner layer of the cell wall and appear perpendicular to the cell surface forming a fibrillar protein coat (Fig 1A). The polysaccharide rich inner layer is mainly made up of β-1,6and β-1,3-glucans and chitin while β-1,3-glucans and chitin are the structural polysaccharides in the cell wall. The development of antifungal therapies that target the cell wall has received great attention (Fig 1A) but with only limited success. The only cell wall-targeting antifungal agents, licenced for human infections, are echinocandins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 1×
“However, not all FKS1 mutations are associated with reduced susceptibility to the echinocandins [28].”
BackgroundMolecular organization of the cell wall of Candida albicans and its relation to pathogenicity
Ruiz-Herrera, J., Victoria Elorza, M., ValentÃn, E., & Sentandreu, R. (2006) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2005.00017.x · Cited by 376 · cited 1×
“β-1,3-glucan β-1,3-glucan is a polymer of glucose units and can exist in a stable triple helical structure which gives it some degree of elasticity and tensile strength making it the main structural polysaccharide in the cell wall of most fungi [5].”
BackgroundEdwards, J. E., Schwartz, M. M., Schmidt, C. S., Sobel, J. D., Nyirjesy, P., Schodel, F., Marchus, E., Lizakowski, M., DeMontigny, E. A., Hoeg, J., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy185 · Cited by 213
Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo
Lee, K. K., MacCallum, D. M., Jacobsen, M. D., Walker, L. A., Odds, F. C., Gow, N. A. R., & Munro, C. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00683-11 · Cited by 209 · cited 1×
“albicans cells with elevated chitin content in the wall are less susceptible to caspofungin treatment in vitro and in vivo [30].”
BackgroundSelf-citationSpellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, Jr. (2006) · The Journal of Infectious Diseases · doi:10.1086/504691 · Cited by 180 · cited 1×
“Human trials with the rAls3-N vaccine are ongoing [24], and data show that the vaccine is safe and induce rapid and robust immune response [25].”
BackgroundBen-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162
Castanheira, M., Messer, S. A., Rhomberg, P. R., & Pfaller, M. A. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.02.009 · Cited by 159 · cited 1×
“Recently, the SENTRY surveillance project has examined the prevalence of FKS1 mutations in echinocandin-resistant isolates and found that the majority of resistant isolates of the major pathogenic Candida species tested do not harbour these mutations [29] suggesting that alternative mechanisms including cell wall remo…”
BackgroundCandida albicans Hyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target
Luo, G., Ibrahim, A. S., Spellberg, B., Nobile, C. J., Mitchell, A. P., & Fu, Y. (2010) · The Journal of Infectious Diseases · doi:10.1086/652407 · Cited by 125
Gilbert, N. M., Donlin, M. J., Gerik, K. J., Specht, C. A., Djordjevic, J. T., Wilson, C. F., Sorrell, T. C., & Lodge, J. K. (2010) · Molecular Microbiology · doi:10.1111/j.1365-2958.2010.07119.x · Cited by 113
Lamoth, F., & Alexander, B. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00234-15 · Cited by 100
Cited by
Architecture of the dynamic fungal cell wall
Gow, N. A. R., & Lenardon, M. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00796-9 · Cited by 447
Emerging Antifungal Targets and Strategies
Ivanov, M., Ćirić, A., & Stojković, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052756 · Cited by 160
“Those enzymes are included in cell wall synthesis, thus are attractive antifungal targets since inhibiting their synthesis and localization to the cell wall could stroke on virulence and cell wall biosynthesis significantly [136].”
BackgroundCryo-EM structure of the β-1,3-glucan synthase FKS1-Rho1 complex
Li, J., Liu, H., Li, J., Liu, J., Dai, X., Zhu, A., Xiao, Q., Qian, W., Li, H., Guo, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57152-7 · Cited by 33
Metadata
- Authors
- Ibe, C., & Munro, C. A.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-22
- Volume
- 17
- Issue
- 4
- Pages
- e1009470
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W3139383323
- Cited by
- 96
- References
- 13
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fungal cell wall: An underexploited target for antifungal therapies. https://app.cochat.ai/papers/10.1371/journal.ppat.1009470
- The paper
- Ibe, C., & Munro, C. A. (2021). Fungal cell wall: An underexploited target for antifungal therapies. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1009470
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.